loading...| Preferred Name |
pramipexole dihydrochloride |
|
| Synonyms |
Mirapex |
|
| Definitions |
The hydrochloride salt of pramipexole, a benzothiazole derivative. As a nonergot dopamine agonist, pramipexole binds to D2 and D3 dopamine receptors in the striatum and substantia nigra of the brain. Compared to other dopamine agonists, the use of this agent may be associated with fewer dyskinetic side effects in treated subjects. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C29374" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29374" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000779012 |
|
| altLabel |
Mirapex |
|
| CAS Registry |
191217-81-9 |
|
| cui |
C0772054 C0721754 |
|
| DATE FIRST PUBLISHED |
2016-02-24 |
|
| Date last modified |
2016-02-24 |
|
| definition |
The hydrochloride salt of pramipexole, a benzothiazole derivative. As a nonergot dopamine agonist, pramipexole binds to D2 and D3 dopamine receptors in the striatum and substantia nigra of the brain. Compared to other dopamine agonists, the use of this agent may be associated with fewer dyskinetic side effects in treated subjects. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C29374" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29374" NCI Thesaurus) |
|
| LT |
TRD |
|
| NCI ID |
C29374 |
|
| notation |
CDR0000779012 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
pramipexole dihydrochloride |
|
| tui |
T109 T121 |